Insulin resistance, a hallmark of T2DM, results in hyperinsulinemia eliciting elevated insulin-like growth factor 1 (IGF1) levels which promote cell growth and proliferation of mucosa cells in the large intestine [5,6]. The gene discussed is IGF1; the disease is hyperinsulinism.